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Clinical Significance of the Pattern of Lymph Node Metastasis 
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Ki Bin Han, You Jin Jang, Jong Han Kim, Sung Soo Park, Seong Heum Park, 
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Purpose: When performing a laparoscopic assisted gastrectomy, a function-preserving gastrectomy is performed depending on the loca-
tion of the primary gastric cancer. This study examined the incidence of lymph node metastasis by the lymph node station number by 
tumor location to determine the optimal extent of the lymph node dissection. 
Materials and Methods: The subjects consisted of 1,510 patients diagnosed with gastric cancer who underwent a gastrectomy between 
1996 and 2005. The patients were divided into three groups: upper, middle and lower third, depending on the location of the primary 
tumor. The lymph node metastasis patterns were analyzed in the total and early gastric cancer patients.
Results: In all patients, lymph node station numbers 1, 2, 3, 7, 10 and 11 metastases were dominant in the cancer originating in the 
upper third, whereas station numbers 4, 5, 6 and 8 were dominant in the lower third. In early gastric cancer patients, the station num-
ber of lymph nodes with a metastasis did not show a significant difference in stage pT1a disease. On the other hand, a metastasis in 
lymph node station number 6 was dominant in stage pT1b disease that originated in the lower third of the stomach. 
Conclusions: When performing a laparoscopic-assisted gastrectomy for early gastric cancer, a limited lymphadenectomy is considered 
adequate during a function-preserving gastrectomy in mucosal (T1a) cancer. On the other hand, for submucosal (T1b) cancer, a number 
6 node dissection should be performed when performing a pylorus preserving gastrectomy.
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Introduction
Endoscopic resection has been performed widely in recent 
times to enable rapid recovery after early gastric cancer treatment. 
However, with the rate of lymph node metastasis reportedly close 
to 20% in cancer invading into the submucosal layer, endoscopic 
resection has its limitations.(1,2) Accordingly, for early gastric can-
cer invading beyond the middle of the submucosal layer (SM2) - 
itself a contraindication to endoscopic resection - open gastrectomy 
is required.(3,4) 
When performing gastrectomy for early gastric cancer, where 
radical resection is viable, laparoscopic assisted gastrectomy which 
enables rapid recovery with less pain compared to open abdominal 
surgery is on the rise.(5) However, lymphadenectomy cannot be 
performed readily in a wide area with laparoscopic assisted gas-
trectomy compared to open gastrectomy due to limited surgical 
visibility and restricted surgical instrument mobility. Consequently, 
inadequate lymphadenectomy may result that negatively impacts 
on patient prognosis. On the other hand, if unnecessarily extensive 
lymphadenectomy is performed in a wide area, the incidence of 
post-surgical complications and morbidity increases.(6) 
Recently, during laparoscopic assisted gastrectomy for early 
gastric cancer, function-preserving gastrectomy, such as proximal 
gastrectomy and pylorus-preserving gastrectomy, is performed 
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in selected cases depending on the tumor location. In such cases, 
partial lymphadenectomy can be performed instead of extensive 
lymphadenectomy.(7,8)
However, the presence or absence of lymph node metastasis is 
very important for the prognosis of gastric cancer.(9) As such, the 
extent of lymphadenectomy should be determined considering the 
patient prognosis and post-surgical complications.
To date, laparoscopic assisted gastrectomy is limited to early 
gastric cancer. However, if the flow of lymph node metastasis de-
pending on the gastric cancer location can be elucidated, guidelines 
on extending laparoscopic assisted gastrectomy to advanced gastric 
cancer may be suggested.
The aims of this study were to examine the incidence of metas-
tasis in lymph node stations by primary gastric cancer location to 
determine the optimal extent of lymphadenectomy and function-
preserving surgery in early gastric cancer patients.
Materials and Methods
Among 1,701 patients diagnosed with gastric cancer who un-
derwent gastrectomy at our institution from 1996 to 2005, 22 pa-
tients developed invasion throughout the entire stomach were not 
classified and therefore excluded from this study. A total of 1,679 
patients were included and classified into 3 groups, based on the 
location of the primary lesion: in the upper third (the upper third 
group), the middle third (the middle third group) and the lower 
third (the lower third group). The upper third designated cancer 
developed in the gastric cardia and fundus, the middle third des-
ignated cancer in the gastric body and the lower third designated 
cancer in the antrum and pylorus.
The upper third group was comprised of 188 patients, the mid-
dle third group was comprised of 605 patients, and the lower third 
group was comprised of 886 patients. Excluding 109 patients with 
tumor invasion into adjacent organs (T4) and 60 patients with un-
classified extent of tumor invasion of the 3 aforementioned groups, 
169 patients with cancer originated in the upper third, 561 patients 
in the middle third and 790 patients in the lower third were ana-
lyzed.
The clinico-pathological characteristics and patterns of lymph 
node metastasis were analyzed by the depth of tumor invasion. The 
tumor stage was classified according to the UICC, sixth edition.(10) 
Metastasis of the first and second tier lymph nodes was evaluated 
according to standards established by the Japanese Gastric Cancer 
Association (JGCA) to determine the extent of lymphadenectomy. 
To help decide surgical intervention by minimally invasive surgery, 
the depth of tumor invasion was subdivided into the mucosal and 
submucosal layers. 
Regarding the pattern of lymph node metastasis of first tier 
lymph nodes based on the classification criteria of the JGCA for 
gastric cancer located in the upper third, the lymph node station 
numbers are defined as 1, 2, 3, 4sa and 4sb. In the middle third, 
the lymph node station numbers are defined as 1, 3, 4sb, 4d, 5 and 
6 while that in the lower third are defined as 3, 4d, 5 and 6. As for 
second tier lymph nodes, the upper third lymph node station num-
bers are defined as 4d, 7, 8a, 9, 10 and 11, that of the middle third 
are defined as 7, 8a, 9, 11p and 12a, and that of the lower third are 
defined as 1, 7, 8a, 9, 11p, 12a and 14v.(11) 
In this study, the total number of lymph node metastasis iden-
tified in 1,510 patients was 1,419. The number of lymph nodes 
metastasis higher than 12 were found in 29 patients, which cor-
responded to third tier lymph nodes or distant metastasis regardless 
of gastric cancer location and were thus excluded. As such, only 1,390 
confirmed metastases in lymph node stations number 1 through to 
11 were included in this study. 
The station number of each lymph node was determined im-
mediately after resection based on the location of blood vessels 
neighboring the stomach, the anatomical location in accordance 
with the standards established by the JGCA. Metastases in the 
classified lymph nodes and resected specimens were determined 
microscopically by specialist pathologists.
For statistical analysis, SPSS ver. 13.0 (SPSS Inc., Chicago, IL, 
USA) was used. For comparative analysis of the clinicopathological 
factors and the incidence of lymph node metastasis depending on 
the position of the tumor, Chi-square test and Student`s t-test was 
applied. A P-value under 0.05 (P＜0.05) was defined as statistically 
significant.
Results
In total, 650 patients had pT1 disease with tumor invasion into 
the mucosal and submucosal layers, 273 patients had pT2 disease 
with invasion into the muscle and subserosal layers and 587 patients 
had pT3 disease with the invasion into the serosa. When tumors 
were classified based on location and characteristics, cancer devel-
oped in the middle third was relatively more prevalent than in the 
upper and lower third in females (P=0.003). As for age, cancer in 
the lower third was more common than in the upper and middle 
third in patients older than 50 years (P＜0.001). For disease in the Han KB, et al.
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upper third, pT3 was relatively more prevalent compared to the 
middle and lower third (P＜0.001). Regarding surgical methods, 
total gastrectomy was more commonly performed for disease in 
the upper third than in the middle and lower third (P＜0.001). Tu-
mors of diameter exceeding 3 cm were more abundant in the upper 
third than in the middle and lower third (P=0.002). Undifferenti-
ated tumors were prevalent in the upper and middle third, while 
differentiated tumors were abundant in the lower third (P＜0.001). 
Lymphatic and perineural invasion was more prevalent in the up-
per third of the stomach in comparison with the middle and lower 
third. Concerning the TNM stage, disease in the upper third was 
more advanced compared to the middle and lower third (P＜0.001) 
(Table 1).
When the incidence of lymph node metastasis was compared 
by the depth of tumor invasion, metastasis in pT1 turned out to 
be 64/650 (9.8%), pT2 turned out to be 114/273 (41.8%) and pT3 
Table 1. Patient's characteristics according to the tumor location
Upper 1/3 (n=159) Middle 1/3 (n=561) Lower 1/3 (n=790) P-value
Sex  F   52 (32.7%) 234 (41.7%) 262 (33.2%) 0.003*
  M 107 (67.3%) 327 (58.3%) 528 (66.8%)
Age  ≤50   50 (31.4%) 196 (34.9%) 192 (24.3%) <0.001*
  >50 109 (68.6%) 365 (65.1%) 598 (75.7%)
Depth of inv.  T1   34 (21.4%) 264 (47.1%) 352 (44.6%) <0.001*
  T2   34  (21.4%)   88 (15.7%) 151 (19.1%)
  T3   91 (57.2%) 209 (37.3%) 287 (36.3%)
Gastrectomy  Total 155 (97.5%) 231 (41.2%)   87 (11.0%) <0.001*
  Subtotal     4 (2.5%) 330 (58.8%) 703 (89.0%)
Size  ≤3 cm   59 (37.1%) 293 (52.2%) 404 (51.1%) 0.002*
  >3 cm 100 (62.9%) 268 (47.8%) 386 (48.9%)
Gross type  0 (superficial spreading)   33 (20.8%) 263 (46.9%) 349 (44.2%) <0.001*
  1 (fungating)     6 (3.8%)     8 (1.4%)   10 (1.3%)
  2 (ulcerofungating)   18 (11.3%)   37 (6.6%)   64 (8.1%)
  3 (ulceroinfiltrative)   80 (50.3%) 167 (29.8%) 307 (38.9%)
  4 (diffuse infiltrative)   19 (11.9%)   71 (12.7%)   55 (7.0%)
  5 (unclassified)     3 (1.9%)   15 (2.7%)     5 (0.6%)
Differentiation  Differentiated   72 (46.5%) 209 (38.3%) 478 (62.0%) <0.001*
  Undifferentiated   83 (53.5%) 336 (61.7%) 293 (38.0%)
Lymphatic emboli  No   27 (36.0%) 114 (54.0%) 162 (52.1%) 0.022*
  Yes   48 (64.0%)   97 (46.0%) 149 (47.9%)
Venous emboli  No   66 (90.4%) 166 (81.4%) 244 (80.8%) 0.145
  Yes     7 (9.6%)   38 (18.6%)   58 (19.2%)
Perineural invasion  No   34 (46.6%) 120 (58.0%) 205 (67.9%) 0.001*
  Yes   39 (53.4%)   87 (42.0%)   97 (32.1%)
Lymph node stage  N0   74 (46.5%) 316 (56.4%) 420 (53.2%) 0.059
  N1   46 (28.9%) 112 (20.0%) 199 (25.2%)
  N2   20 (12.6%)   71 (12.7%) 107 (13.5%)
  N3   19 (11.9%)   61 (10.9%)   64 (8.1%)
Stage  1   33 (20.8%) 237 (42.2%) 316 (40.0%) <0.001*
  2   18 (11.3%)   67 (11.9%)   99 (12.5%)
  3 108 (67.9%) 257 (45.8%) 375 (47.5%)
*P<0.05: statistically significant.The Pattern of Lymph Node Metastasis of Gastric Cancer
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turned out to be 341/587 (58.1%). However, no difference was de-
tected according to tumor location.
When the lymph node stations with metastasis based on tumor 
location were compared, metastasis in station numbers 1, 2, 3, 7, 10 
and 11 was most commonly caused by disease in the upper third, 
while metastasis in station numbers 4, 5, 6 and 8 was significantly 
abundant in the lower third. Number 9 lymph node, however, did 
not show significant difference. Examining cases of lymph node 
Table 2. Number of patients with metastatic lymph nodes according to tumor location
Lymph node 
station number
Upper 1/3
(n=159)
Middle 1/3
(n=561)
Lower 1/3
(n=790)
Total 
(n=1,510) P-value
1 26 (16.4%)   44 (7.8%)   38 (4.8%) 108 <0.001*
2   4 (2.5%)     6 (1.1%)     2 (0.3%) 12 0.009*
3 55 (34.6%) 158 (28.2%) 181 (22.9%) 394 0.003*
4 29 (12.6%) 107 (19.1%) 171 (21.6%) 307 0.028*
5   1 (0.6%)   16 (2.9%)   48 (6.1%) 65 0.001*
6   3 (1.9%)   40 (7.1%) 148 (18.7%) 191 <0.001*
7 20 (12.6%)   42 (7.5%)   47 (5.9%) 109 0.012*
8 10 (6.3%)   28 (5.0%)   83 (10.5%) 121 0.001*
9 10 (6.3%)   21 (3.7%)   31 (3.9%) 62 0.336
10   3 (1.9%)     2 (0.4%)     0 5 0.001*
11   3 (1.9%)   10 (1.8%)     3 (0.4%) 16 0.026*
*P<0.05: statistically significant.
Fig. 1. Percentages of metastatic lymph nodes according to the tumor 
location. (A) Total patient. (B) T1a (mucosa). (C) T1b (Submucosa).Han KB, et al.
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metastasis beyond the second tier, number 7, 10 and 11 lymph 
node metastasis was dominant in the upper third. Number 8 was 
dominant in the lower third and as such, lymph node metastasis 
in the second tier of lymph nodes was abundant in the upper and 
lower third compared to the middle third (Table 2, Fig. 1A).
When dividing early gastric cancer into the mucosal (pT1a) 
and submucosal layer (pT1b) and comparing metastasis with each 
lymph node by tumor location, the number of lymph nodes with 
metastasis did not show significant difference in pT1a. In pT1b, 
metastasis was significantly abundant in the number 6 lymph node 
in disease originated in the lower third. In pT1a, none metastasized 
beyond the second tier in the upper third. As for metastasis beyond 
the second tier lymph nodes in the middle third, number 2 lymph 
node was found positive in 1 patient (0.7%), number 7 in 1 patient 
(0.7%) and number 9 in 2 patients (1.4%). Regarding metastasis 
beyond the second tier lymph nodes in the lower third, number 7 
lymph node was positive in 1 patient (0.5%) and number 9 in 1 pa-
tient (0.5%). However, there was no statistical significance. In pT1b 
in the upper third of the stomach, none metastasized beyond sec-
ond tier lymph nodes. Regarding metastasis beyond the second tier 
in disease originated in the middle third of the stomach, number 
7 lymph node was positive in 2 patients (1.7%). In the lower third, 
number 1 lymph node was positive in 2 patients (1.2%), number 8 
in 3 patients (1.8%), number 9 in 1 patient (0.6%), and number 11 
in 1 patient (0.6%), which was not statistically significant (Table 3, 
Fig. 1B, C).
Discussion
In this study, patients were divided into three groups, the up-
Table 3. Number of patients with metastatic lymph nodes according to the tumor location in early gastric cancer
Lymph node
 station number Upper 1/3  Middle 1/3  Lower 1/3 Total P-value
T1a (mucosa) n=13 n=143 n=182
1 0 1 (0.7%) 0 1 0.505
2 0 1 (0.7%) 0 1 0.505
3 1 (7.7%) 7 (4.9%) 6 (3.3%) 14 0.624
4 1 (7.7%) 3 (2.1%) 1 (0.5%) 5 0.086
5 0 0 1 (0.5%) 1 0.651
6 0 1 (0.7%) 2 (1.1%) 3 0.875
7 0 1 (0.7%) 1 (0.5%) 2 0.946
8 0 0 0 0 .a*
9 0 2 (1.4%) 1 (0.5%) 3 0.678
10 0 0 0 0 .a*
11 0 0 0 0 .a*
T1b (submucosa) n=21 n=121 n=170
1 0 3 (2.5%) 2 (1.2%) 5 0.569
2 1 (4.8%) 0 0 0 .a*
3 0 14 (11.6%) 15 (8.8%) 30 0.542
4 0 7 (5.8%) 11 (6.5%) 18 0.487
5 0 0 0 0 .a*
6 0 2 (1.7%) 13 (7.6%) 15 0.035
†
7 0 2 (1.7%) 0 2 0.204
8 0 0 3 (1.8%) 3 0.282
9 0 0 1 (0.6%) 1 0.658
10 0 0 0 0 .a*
11 0 0 1 (0.6%) 1 0.658
*Not enough data for calculation; 
†P<0.05: statistically significant.The Pattern of Lymph Node Metastasis of Gastric Cancer
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per third, the middle third and the lower third, depending on the 
location of the tumor, and their characteristics were compared. 
Differences were found in age, gender, tumor size, macroscopic 
morphology, differentiation grade, lymph node infiltration, invasion 
to the perineural area and tumor node metastasis (TNM) stage. 
The extent of tumor invasion was relatively severe and lymph node 
metastasis was more common secondary to disease in the upper 
third of the stomach, compared to the middle and lower third. Tu-
mor development was once predominantly found in the lower third 
in contrast to recent observation that more diseases develop in the 
middle third, particularly in the angle of the lesser curvature, and 
the incidence of gastric cancer in the upper third is on the rise.(12) 
According to recent reports, disease is relatively more common in 
the middle and lower third, and tends to be associated with early 
lymph node metastasis. Particularly, there is a tendency of lymph 
node metastasis to the vicinity of the splenic artery and hilum. As 
such, it has been proposed that total gastrectomy, extended lymph-
adenectomy and splenectomy are required to manage disease origi-
nated in the middle and lower third.(13) Nevertheless, due to recent 
advancement in surgical technique, extended lymphadenectomy, 
including lymph node station numbers 10 and 11 in the splenic 
hilum without splenectomy, is being performed widely. At our in-
stitution, gastrectomy for cancer in the upper third is performed by 
such methods.(14)
Recently, with the development of minimally invasive surgical 
techniques such as laparoscopic gastrectomy, much effort has been 
made to avoid total gastrectomy and proximal gastrectomy is being 
commonly performed.(15) As such, it is important to determine the 
range of lymphadenectomy associated with gastrectomy. Due to 
advancement of laparoscopic techniques, it has become possible to 
perform lymphadenectomy while observing the lymph node ana-
tomical structure comprehensively. As a consequence, resection of 
station number 5 and 6 lymph nodes in the vicinity of the pylorus 
area is now possible without resecting the right gastroepiploic ves-
sels below the pylorus and the right gastric vessels above the py-
lorus. However, if such vessels are injured during surgery, ligation 
must be performed to ensure patient safety. Therefore, for gastric 
cancer in the upper third, the range of lymphadenectomy may be 
reduced if the extent of lymph node metastasis in the area is not 
severe. In this study, when gastric cancer developed in the upper 
third, lymph node metastasis would be classified according to the 
depth of tumor invasion. Lymph node metastasis was not detected 
in early gastric cancer invading into the mucosal layer. Accordingly, 
modified lymphadectomy without resecting lymph nodes in the 
vicinity of the pylorus area is considered adequate, when proximal 
gastrectomy is performed on early gastric cancer.
When patient groups were classified based on tumor invasion 
depth, the deeper the invasion, the higher the incidence of lymph 
node metastasis. In Korea, Japan and other countries where gas-
tric cancer incidence is high, lymphadenectomy higher than D2 is 
already being adopted.(16) Nonetheless, in terms of lymphadenec-
tomy for early gastric cancer with low risk of lymph node metasta-
sis, D1+α (resection of number 7 lymph node) or D1+β (resection 
of lymph nodes 7, 8 and 9) is sufficient in some cases. However, 
lymphadenectomy higher than D2 is considered necessary in other 
cases. This remains an area of controversy.(17) 
Recently, sentinel lymph node biopsy has been performed in 
selected cases of early gastric cancers to avoid extensive lymphad-
enectomy. However, sentinel lymphadenectomy is not being prac-
ticed widely due to questionable accuracy and the presence of skip 
metastases.(18) 
Extended lymphadenectomy higher than D2 was considered 
necessary for early gastric cancer in the past.(19) Nonetheless, due 
to the advent of minimally invasive surgical techniques, efforts have 
been made to reduce the extent of lymph node resection. In this 
study, invasion of early gastric cancer was subdivided into the mu-
cosa and the submucosal layers, and metastasis of number 2 lymph 
nodes was not detected in disease originated in the upper third. On 
the other hand, metastasis was identified in number 7 and 9 lymph 
nodes in disease originated from the middle third while metastasis 
in lymph nodes number 1, 7, 8, 9 and 11 was identified in disease 
originated in the lower third. At any rate, the number was meager 
and statistical significance was not detected. On the contrary, in 
disease invaded into the submucosal layer, statistical differences 
were seen in 13 cases of metastasis in lymph nodes below the 
pylorus (number 6) in cancer originated in the lower third of the 
stomach. In summary, when performing laparoscopic gastrectomy 
in early gastric cancer, modified D1+β lymphadenectomy (resection 
of number 7, 8 and 9 lymph nodes) is considered a better option 
than conventional D2 extension lymphadenectomy. In particu-
lar, for diseases shown to have invaded into the mucosal layer at 
the clinical stage, it may be sufficient to perform such modified 
lymphadenectomy. 
 Recently, for early gastric cancer located more than 3 cm 
from the pylorus for the middle third, attempts have been made 
to perform pylorus preserving gastrectomy as a form of function-
preserving gastrectomy. According to recent studies reported by 
Ikeguchi et al. in Japan, the post-surgical quality-of-life was better Han KB, et al.
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when pylorus-preserving gastrectomy was performed compared 
to conventional distal resection.(20,21) However, when perform-
ing such pylorus-preserving gastrectomy, resection of number 5 
and 6 lymph nodes in the vicinity of the pylorus remains techni-
cally challenging. Hence, for gastric cancer originated in the middle 
third, the presence or absence of metastasis in number 5 and 6 
lymph nodes was examined based on the depth of tumor invasion 
in this study.(22) Among all early gastric cancer cases, there was 
1 case of metastasis in number 6 lymph node due to cancer origi-
nated in the middle third restricted to the mucosal layer, and there 
were 2 cases of metastasis in the number 6 lymph node from dis-
ease invading into the submucosal layer. Thus, it may be necessary 
to perform pylorus-preserving gastrectomy and number 6 node 
dissection for disease originated in the middle third with submuco-
sal invasion (pT1b).
The limitations of this study included relatively low incidence of 
gastric cancer in the upper third of the stomach, compared to that 
in the middle and the lower third as well as relatively small patient 
cohort. 
Based on the results, guidelines for modified reduced lymphad-
enectomy that potentially replaces conventional extended lymph-
adenectomy in a wide area can be considered to be adopted when 
function-preserving gastrectomy is performed for the treatment of 
early gastric cancer in the future, to be supported by the conduct of 
a large-scale study.
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